Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate vs Raloxifene in Postmenopausal Osteoporosis
NCT00389740Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Apr 2001
- Primary completion
- Jan 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of alendronate in osteoporosis, sponsored by Organon & Co.. Started Apr 2001; status: completed.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00389740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00389740.